Glecaprevir/Pibrentasvir Combination Within Individual Particles Drives Optimal LAI Performance
CROI 2026 Feb 22-25 Denver
Usman Arshad1,3, Henry Pertinez1,3, Joanne Sharp1,3, Helen Cox1,3, Joanne Herriott1,3, Edyta Kijak1,3, Eduardo Gallardo-Toledo1,3, Jonathan Massam2,3, Alison Savage2,3, James J. Hobson2,3, Catherine Unsworth2,3, David L. Thomas4, Paul Curley1,3, Steve P. Rannard2,3, Andrew Owen1,3
